Nuveen’s Veradigm Inc. Common Stock MDRX Stock Holding History

Nuveen’s Portfolio MDRX Stock Details MDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-845,134	Closed	-$8.87M	–	3324
2023 Q4	$8.87M	Buy	845,134 +116,859	+16%	+$1.43M	﹤0.01%	1663
2023 Q3	$9.57M	Sell	728,275 -137,700	-16%	-$1.81M	﹤0.01%	1507
2023 Q2	$10.9M	Sell	865,975 -459,586	-35%	-$5.58M	﹤0.01%	1468
2023 Q1	$17.3M	Sell	1,325,561 -70,499	-5%	-$1.14M	0.01%	1137
2022 Q4	$24.6M	Buy	1,396,060 +60,964	+5%	+$1.02M	0.01%	904
2022 Q3	$20.3M	Sell	1,335,096 -185,788	-12%	-$3M	0.01%	999
2022 Q2	$22.6M	Buy	1,520,884 +12,305	+0.8%	+$230K	0.01%	969
2022 Q1	$33.5M	Buy	1,508,579 +524,027	+53%	+$10.6M	0.01%	855
2021 Q4	$18.2M	Sell	984,552 -140,625	-12%	-$2.23M	0.01%	1290
2021 Q3	$15M	Sell	1,125,177 -547,142	-33%	-$8.83M	﹤0.01%	1476
2021 Q2	$31M	Sell	1,672,319 -314,394	-16%	-$5.29M	0.01%	1048
2021 Q1	$29.8M	Sell	1,986,713 -64,941	-3%	-$1.04M	0.01%	1033
2020 Q4	$29.6M	Buy	2,051,654 +570,879	+39%	+$6.91M	0.01%	984
2020 Q3	$12.1M	Sell	1,480,775 -33,635	-2%	-$275K	﹤0.01%	1394
2020 Q2	$10.3M	Buy	1,514,410 +130,281	+9%	+$845K	﹤0.01%	1469
2020 Q1	$9.74M	Buy	1,384,129 +457,101	+49%	+$3.71M	﹤0.01%	1304
2019 Q4	$9.1M	Buy	927,028 +148,069	+19%	+$1.56M	﹤0.01%	1645
2019 Q3	$8.55M	Sell	778,959 -1,089	-0.1%	-$11.2K	﹤0.01%	1661
2019 Q2	$9.07M	Buy	+780,048	New	+$7.93M	﹤0.01%	1663
2017 Q2	–	Sell	-57,889	Closed	-$734K	–	1346
2017 Q1	$734K	Sell	57,889 -13,894	-19%	-$165K	﹤0.01%	1064
2016 Q4	$733K	Sell	71,783 -123,454	-63%	-$1.41M	﹤0.01%	1238
2016 Q3	$2.57M	Sell	195,237 -38,000	-16%	-$508K	0.02%	688
2016 Q2	$2.96M	Buy	233,237 +93,500	+67%	+$1.24M	0.02%	630
2016 Q1	$1.85K	Buy	139,737 +63,000	+82%	+$827K	0.01%	781
2015 Q4	$1.18K	Buy	76,737 +11,530	+18%	+$165K	0.01%	993
2015 Q3	$809	Hold	65,207	–	–	﹤0.01%	1173
2015 Q2	$892	Hold	65,207	–	–	﹤0.01%	1203
2015 Q1	$780K	Sell	65,207 -8,481	-12%	-$104K	﹤0.01%	1246
2014 Q4	$941K	Hold	73,688	–	–	0.01%	1201
2014 Q3	$989K	Buy	73,688 +3,422	+5%	+$51.9K	0.01%	1148
2014 Q2	$1.13M	Buy	70,266 +198	+0.3%	+$3.09K	0.01%	1100
2014 Q1	$1.26M	Hold	70,068	–	–	0.01%	1011
2013 Q4	$1.08M	Sell	70,068 -103,436	-60%	-$1.52M	0.01%	1066
2013 Q3	$2.58M	Buy	173,504 +99,169	+133%	+$1.5M	0.02%	704
2013 Q2	$962K	Buy	+74,335	New	+$996K	0.01%	1050

Other funds holding MDRX

SPC

Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

TCM

Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return

OFCM

One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nuveen's MDRX Position: Q1 2024 in Review

Nuveen sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 845,134 shares — an estimated $8.87M sold.

Nuveen first reported a position in MDRX in Q2 2013 and held it in 35 quarters. The position peaked at $33.5M in Q1 2022. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

Nuveen reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Nuveen sold 845,134 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $8.87M.
Nuveen first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 35 quarters.
Nuveen's Veradigm Inc. Common Stock position peaked at $33.5M in Q1 2022.
35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Nuveen's 13F filing for Q1 2024, filed 13 May 2024.